Vascular Sealing Medical Glue Market By Procedure (Revascularization, Others) , By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The vascular sealing medical glue market was valued at $0.7 billion in 2023, and is projected t%li%reach $1.4 billion by 2033, growing at a CAGR of 7.3% from 2024 t%li%2033.
Vascular sealing medical glue is a surgical adhesive that possesses high adhesive and hemostatic properties, and is used t%li%seal and reinforce tissues. These adhesives are play a pivotal role in creating functional connections between damaged tissues and between tissues and implanted biomaterials. They are majorly developed t%li%minimize the use of surgical sutures and mechanical methods of tissue fusion, which are useful in conventional surgeries. This is attributed t%li%the fact that vascular sealing glues promote tissue regeneration and healing, mitigate the risk of infection, and minimize tissue trauma as compared t%li%conventional methods. Natural medical adhesives available in the market include fibrin adhesives and collagen-based products, which are highly effective in adhesion.
The growth of the global vascular sealing medical glue market is majorly driven by alarming rise in prevalence of cardiovascular diseases and corresponding increase in need for surgeries, such as angioplasty and coronary artery bypass grafting, are boosting the demand for vascular sealing medical glue. According t%li%the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared t%li%any other cause. Approximately 20.5 million die every year due t%li%cardiovascular diseases. Of these deaths, 85% are due t%li%coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed t%li%the fact that aged individuals are highly susceptible t%li%cardiac diseases and often require procedures t%li%address issues such as varicose veins and atherosclerosis, thus increasing the need for vascular sealing glues. As per the article published by the Revista Espa?ola de Cardiologнa—the official publication of the Spanish Society of Cardiology—coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers due t%li%quicker recovery times and reduced hospital stays fosters the growth of the market. However, safety concerns associated with vascular sealing medical glue hamper the growth of the market. For instance, some adhesives are cytotoxic and are poorly absorbed, which limit their demand in healthcare settings. Furthermore, inability t%li%medical adhesives t%li%provide adequate and immediate seal, increased risk of infection, and delayed healing act as the key deterrent factors of the market. On the contrary, t%li%reduce the risk of infection at the surgical sites, manufacturers are developing vascular sealing medical glue with antimicrobial properties, thus ensuring post-operative care and patient safety. In addition, continuous innovations in the formulation of medical glues t%li%enhance their adhesive strength are expected t%li%offer lucrative opportunities for the expansion of the market during the forecast period.
The global vascular sealing medical glue market is segmented int%li%procedure, end user, and region. By procedure, the market is categorized int%li%revascularization and others. On the basis of end user, it is divided int%li%hospitals, specialty clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
Competitive analysis and profiles of the major players in the global vascular sealing medical glue market include Baxter International Inc., Becton, Dickinson and Company, Artivion, Inc., Success Bio-tech, Integra LifeSciences Holdings Corporation, Stryker Corporation, Abbott Laboratories, Terum%li%Corporation, Johnson & Johnson, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
By Procedure
Vascular sealing medical glue is a surgical adhesive that possesses high adhesive and hemostatic properties, and is used t%li%seal and reinforce tissues. These adhesives are play a pivotal role in creating functional connections between damaged tissues and between tissues and implanted biomaterials. They are majorly developed t%li%minimize the use of surgical sutures and mechanical methods of tissue fusion, which are useful in conventional surgeries. This is attributed t%li%the fact that vascular sealing glues promote tissue regeneration and healing, mitigate the risk of infection, and minimize tissue trauma as compared t%li%conventional methods. Natural medical adhesives available in the market include fibrin adhesives and collagen-based products, which are highly effective in adhesion.
The growth of the global vascular sealing medical glue market is majorly driven by alarming rise in prevalence of cardiovascular diseases and corresponding increase in need for surgeries, such as angioplasty and coronary artery bypass grafting, are boosting the demand for vascular sealing medical glue. According t%li%the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared t%li%any other cause. Approximately 20.5 million die every year due t%li%cardiovascular diseases. Of these deaths, 85% are due t%li%coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed t%li%the fact that aged individuals are highly susceptible t%li%cardiac diseases and often require procedures t%li%address issues such as varicose veins and atherosclerosis, thus increasing the need for vascular sealing glues. As per the article published by the Revista Espa?ola de Cardiologнa—the official publication of the Spanish Society of Cardiology—coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers due t%li%quicker recovery times and reduced hospital stays fosters the growth of the market. However, safety concerns associated with vascular sealing medical glue hamper the growth of the market. For instance, some adhesives are cytotoxic and are poorly absorbed, which limit their demand in healthcare settings. Furthermore, inability t%li%medical adhesives t%li%provide adequate and immediate seal, increased risk of infection, and delayed healing act as the key deterrent factors of the market. On the contrary, t%li%reduce the risk of infection at the surgical sites, manufacturers are developing vascular sealing medical glue with antimicrobial properties, thus ensuring post-operative care and patient safety. In addition, continuous innovations in the formulation of medical glues t%li%enhance their adhesive strength are expected t%li%offer lucrative opportunities for the expansion of the market during the forecast period.
The global vascular sealing medical glue market is segmented int%li%procedure, end user, and region. By procedure, the market is categorized int%li%revascularization and others. On the basis of end user, it is divided int%li%hospitals, specialty clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
- By procedure, the revascularization segment dominated the market share in 2023.
- On the basis of end user, the hospitals segment exhibited the highest growth in 2023.
- Region wise, North America lead the market in 2023; however, Asia-Pacific is expected t%li%register highest CAGR during the forecast period.
Competitive analysis and profiles of the major players in the global vascular sealing medical glue market include Baxter International Inc., Becton, Dickinson and Company, Artivion, Inc., Success Bio-tech, Integra LifeSciences Holdings Corporation, Stryker Corporation, Abbott Laboratories, Terum%li%Corporation, Johnson & Johnson, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
By Procedure
- Revascularization
- Others
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Baxter International Inc.
- Becton, Dickinson and Company
- Artivion, Inc.
- Success Bio-tech
- Integra LifeSciences Holdings Corporation
- Stryker Corporation
- Abbott Laboratories
- Terum%li%Corporation
- Johnson & Johnson
- Medtronic
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Hardware
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Software
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Services
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Augmented Reality
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Virtual Reality
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Research Institutions
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Diagnostic Centers
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Clinics
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Component
7.2.3. Market Size and Forecast, By Technology
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Virtual and Augmented Reality in Healthcare Market
7.2.6.1. Market Size and Forecast, By Component
7.2.6.2. Market Size and Forecast, By Technology
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Virtual and Augmented Reality in Healthcare Market
7.2.7.1. Market Size and Forecast, By Component
7.2.7.2. Market Size and Forecast, By Technology
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Virtual and Augmented Reality in Healthcare Market
7.2.8.1. Market Size and Forecast, By Component
7.2.8.2. Market Size and Forecast, By Technology
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Component
7.3.3. Market Size and Forecast, By Technology
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Virtual and Augmented Reality in Healthcare Market
7.3.6.1. Market Size and Forecast, By Component
7.3.6.2. Market Size and Forecast, By Technology
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Virtual and Augmented Reality in Healthcare Market
7.3.7.1. Market Size and Forecast, By Component
7.3.7.2. Market Size and Forecast, By Technology
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Virtual and Augmented Reality in Healthcare Market
7.3.8.1. Market Size and Forecast, By Component
7.3.8.2. Market Size and Forecast, By Technology
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Virtual and Augmented Reality in Healthcare Market
7.3.9.1. Market Size and Forecast, By Component
7.3.9.2. Market Size and Forecast, By Technology
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Virtual and Augmented Reality in Healthcare Market
7.3.10.1. Market Size and Forecast, By Component
7.3.10.2. Market Size and Forecast, By Technology
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Virtual and Augmented Reality in Healthcare Market
7.3.11.1. Market Size and Forecast, By Component
7.3.11.2. Market Size and Forecast, By Technology
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Component
7.4.3. Market Size and Forecast, By Technology
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Virtual and Augmented Reality in Healthcare Market
7.4.6.1. Market Size and Forecast, By Component
7.4.6.2. Market Size and Forecast, By Technology
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Virtual and Augmented Reality in Healthcare Market
7.4.7.1. Market Size and Forecast, By Component
7.4.7.2. Market Size and Forecast, By Technology
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Virtual and Augmented Reality in Healthcare Market
7.4.8.1. Market Size and Forecast, By Component
7.4.8.2. Market Size and Forecast, By Technology
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Virtual and Augmented Reality in Healthcare Market
7.4.9.1. Market Size and Forecast, By Component
7.4.9.2. Market Size and Forecast, By Technology
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Virtual and Augmented Reality in Healthcare Market
7.4.10.1. Market Size and Forecast, By Component
7.4.10.2. Market Size and Forecast, By Technology
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Virtual and Augmented Reality in Healthcare Market
7.4.11.1. Market Size and Forecast, By Component
7.4.11.2. Market Size and Forecast, By Technology
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Component
7.5.3. Market Size and Forecast, By Technology
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Virtual and Augmented Reality in Healthcare Market
7.5.6.1. Market Size and Forecast, By Component
7.5.6.2. Market Size and Forecast, By Technology
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Virtual and Augmented Reality in Healthcare Market
7.5.7.1. Market Size and Forecast, By Component
7.5.7.2. Market Size and Forecast, By Technology
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Virtual and Augmented Reality in Healthcare Market
7.5.8.1. Market Size and Forecast, By Component
7.5.8.2. Market Size and Forecast, By Technology
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Virtual and Augmented Reality in Healthcare Market
7.5.9.1. Market Size and Forecast, By Component
7.5.9.2. Market Size and Forecast, By Technology
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. CAE
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. GE Healthcare
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Koninklijke Philips N.V.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Intuitive Surgical, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Siemens Ltd
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Eon Reality, Inc
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Bioflight VR
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. WorldViz
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. TheraSim Inc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. MindMaze
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY COMPONENT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Component
4.2. Hardware
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Software
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Services
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Augmented Reality
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Virtual Reality
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Research Institutions
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Diagnostic Centers
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Clinics
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: VIRTUAL AND AUGMENTED REALITY IN HEALTHCARE MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Component
7.2.3. Market Size and Forecast, By Technology
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Virtual and Augmented Reality in Healthcare Market
7.2.6.1. Market Size and Forecast, By Component
7.2.6.2. Market Size and Forecast, By Technology
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Virtual and Augmented Reality in Healthcare Market
7.2.7.1. Market Size and Forecast, By Component
7.2.7.2. Market Size and Forecast, By Technology
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Virtual and Augmented Reality in Healthcare Market
7.2.8.1. Market Size and Forecast, By Component
7.2.8.2. Market Size and Forecast, By Technology
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Component
7.3.3. Market Size and Forecast, By Technology
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Virtual and Augmented Reality in Healthcare Market
7.3.6.1. Market Size and Forecast, By Component
7.3.6.2. Market Size and Forecast, By Technology
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Virtual and Augmented Reality in Healthcare Market
7.3.7.1. Market Size and Forecast, By Component
7.3.7.2. Market Size and Forecast, By Technology
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Virtual and Augmented Reality in Healthcare Market
7.3.8.1. Market Size and Forecast, By Component
7.3.8.2. Market Size and Forecast, By Technology
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Virtual and Augmented Reality in Healthcare Market
7.3.9.1. Market Size and Forecast, By Component
7.3.9.2. Market Size and Forecast, By Technology
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Virtual and Augmented Reality in Healthcare Market
7.3.10.1. Market Size and Forecast, By Component
7.3.10.2. Market Size and Forecast, By Technology
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Virtual and Augmented Reality in Healthcare Market
7.3.11.1. Market Size and Forecast, By Component
7.3.11.2. Market Size and Forecast, By Technology
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Component
7.4.3. Market Size and Forecast, By Technology
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Virtual and Augmented Reality in Healthcare Market
7.4.6.1. Market Size and Forecast, By Component
7.4.6.2. Market Size and Forecast, By Technology
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Virtual and Augmented Reality in Healthcare Market
7.4.7.1. Market Size and Forecast, By Component
7.4.7.2. Market Size and Forecast, By Technology
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Virtual and Augmented Reality in Healthcare Market
7.4.8.1. Market Size and Forecast, By Component
7.4.8.2. Market Size and Forecast, By Technology
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Virtual and Augmented Reality in Healthcare Market
7.4.9.1. Market Size and Forecast, By Component
7.4.9.2. Market Size and Forecast, By Technology
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Virtual and Augmented Reality in Healthcare Market
7.4.10.1. Market Size and Forecast, By Component
7.4.10.2. Market Size and Forecast, By Technology
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Virtual and Augmented Reality in Healthcare Market
7.4.11.1. Market Size and Forecast, By Component
7.4.11.2. Market Size and Forecast, By Technology
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Component
7.5.3. Market Size and Forecast, By Technology
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Virtual and Augmented Reality in Healthcare Market
7.5.6.1. Market Size and Forecast, By Component
7.5.6.2. Market Size and Forecast, By Technology
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Virtual and Augmented Reality in Healthcare Market
7.5.7.1. Market Size and Forecast, By Component
7.5.7.2. Market Size and Forecast, By Technology
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Virtual and Augmented Reality in Healthcare Market
7.5.8.1. Market Size and Forecast, By Component
7.5.8.2. Market Size and Forecast, By Technology
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Virtual and Augmented Reality in Healthcare Market
7.5.9.1. Market Size and Forecast, By Component
7.5.9.2. Market Size and Forecast, By Technology
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. CAE
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. GE Healthcare
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Koninklijke Philips N.V.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Intuitive Surgical, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Siemens Ltd
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Eon Reality, Inc
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Bioflight VR
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. WorldViz
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. TheraSim Inc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. MindMaze
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
